Alaunos Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $3 | $0 | $0 |
Gross Profit | -8 | 3 | -185 | |
EBITDA | -1,012 | -900 | -1,159 | -1,038 |
EBIT | -907 | -1,159 | -1,038 | |
Net Income | -1,006 | -893 | -1,159 | -1,051 |
Net Change In Cash | 0 | 3 | 0 | 0 |
Free Cash Flow | -1,030 | -553 | -941 | -701 |
Cash | 354 | 1,385 | 1,938 | 2,879 |
Basic Shares | 1,948 | 1,948 | 2,183 | 1,676 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5 | $10 | $5 | $2,922 |
Gross Profit | 5 | 10 | -4,798 | 2,922 |
EBITDA | -4,225 | -4,677 | -30,904 | -31,817 |
EBIT | -4,232 | -4,679 | -33,219 | -34,576 |
Net Income | -4,176 | -4,679 | -35,140 | -37,730 |
Net Change In Cash | 5 | 10 | 5 | 2,922 |
Cost of Revenue | -23,058 | |||
Free Cash Flow | -2,967 | -4,971 | -30,339 | -29,448 |
Cash | 1,385 | 1,091 | 6,062 | 39,058 |
Basic Shares | 1,948 | 1,601 | 1,599 | 1,447 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.55 |
2025-06-30 | -$0.63 |
2025-03-31 | -$0.67 |
2024-12-31 | -$0.46 |